Literature DB >> 10484287

Consequences of treatment with dexamethasone in rats on the susceptibility of total plasma and isolated lipoprotein fractions to copper oxidation.

D Belkebir-Mesbah1, D Bonnefont-Rousselot, V Frey-Fressart, C Moinard, J Delattre, M P Vasson.   

Abstract

According to the oxidative hypothesis of atherosclerosis, a hyperoxidizability of lipoproteins could favor the development of the atherosclerotic process. Besides, it has been recently reported that models of elevated very-low-density-lipoprotein (VLDL) levels in rats resulted in an increased susceptibility of these VLDL to oxidation. Treatment with dexamethasone classically induces an increase in plasma VLDL concentration. The aim of our study was thus to assess the effects of a treatment with dexamethasone in rats on the susceptibility to copper oxidation, both on total plasma and on isolated lipoproteins. Male Sprague-Dawley rats aged three months were treated with a daily intraperitoneal injection of dexamethasone (1.5 mg per kg) for five days (DEX group), whereas control rats were fed ad libitum (AL group). In order to take into account the decrease of food intake induced by dexamethasone treatment, a group of pair-fed rats was constituted (PF group). These rats had the same food intake as rats of the DEX group and were treated with a daily isovolumic intraperitoneal injection of NaCl for 5 d. After 5 d treatment, rats were fasted overnight, then killed, and blood was collected on EDTA. Low-density lipoproteins (VLDL + LDL) and high-density lipoproteins (HDL) were isolated by ultracentrifugation. A copper oxidation was conducted both on total plasma and on isolated lipoproteins. As expected, after treatment with dexamethasone, plasma exhibited increased triglyceride and glucose levels. Similarly, VLDL + LDL of rats from the DEX group were enriched with triglycerides, when compared with VLDL + LDL of the other two groups of rats. Our major finding was a marked increase in the susceptibility of total plasma of the DEX group to copper oxidation, in comparison with the other two groups of rats. This oxidizability was assessed by the maximal level of oxidation products absorbing at 234 nm and classically considered to be conjugated dienes (7.46+/-0.70 micromol L(-1) in the DEX group vs. 3.36+/-0.40 and 2.05+/-0.60 micromol L(-1) in the AL and PF groups, respectively). Nevertheless, this higher oxidizability was not observed in the isolated lipoprotein fractions, as shown by the formation of lipid peroxidation products such as conjugated dienes, thiobarbituric-acid reactive substances, hydroperoxides, 7-ketocholesterol, and dienals. This is not in agreement with other models of hypertriglyceridemia that have been reported to induce a hyperoxidizability of lipoproteins in rats. Our results led us to hypothesize that other plasma components such as proteins could be involved in this susceptibility to oxidation. Indeed, the severe protein catabolism induced by dexamethasone treatment could support this hypothesis, by forming protein components that are more susceptible to oxidation, as shown by an increased carbonyl formation upon plasma copper oxidation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10484287     DOI: 10.1007/BF02738622

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  45 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Moderate zinc deficiency in rats enhances lipoprotein oxidation in vitro.

Authors:  R A DiSilvestro; A Blostein-Fujii
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

Review 3.  Relative value of carotenoids as precursors of vitamin A.

Authors:  K L Simpson
Journal:  Proc Nutr Soc       Date:  1983-01       Impact factor: 6.297

4.  [A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method].

Authors:  M Eggstein; F H Kreutz
Journal:  Klin Wochenschr       Date:  1966-03-01

5.  The regulation of lipoprotein lipase gene expression by dexamethasone in isolated rat adipocytes.

Authors:  J M Ong; R B Simsolo; B Saffari; P A Kern
Journal:  Endocrinology       Date:  1992-04       Impact factor: 4.736

6.  Melatonin protects rats from injurious effects of a glucocorticoid, dexamethasone.

Authors:  W Mori; H Aoyama; N Mori
Journal:  Jpn J Exp Med       Date:  1984-12

Review 7.  Is atherosclerosis a complication of long-term corticosteroid treatment?

Authors:  D J Nashel
Journal:  Am J Med       Date:  1986-05       Impact factor: 4.965

8.  Effects of ionizing radiation (neutrons/gamma rays) on plasma lipids and lipoproteins in rats.

Authors:  C Feurgard; D Bayle; F Guézingar; C Sérougne; A Mazur; C Lutton; J Aigueperse; P Gourmelon; D Mathé
Journal:  Radiat Res       Date:  1998-07       Impact factor: 2.841

9.  Glutamine metabolism in skeletal muscle of glucocorticoid-treated rats.

Authors:  M S Ardawi; Y S Jamal
Journal:  Clin Sci (Lond)       Date:  1990-08       Impact factor: 6.124

10.  Continuous monitoring of intermediates and final products of oxidation of low density lipoprotein by means of UV-spectroscopy.

Authors:  I Pinchuk; D Lichtenberg
Journal:  Free Radic Res       Date:  1996-05
View more
  1 in total

1.  Detection of apoptotic cell death in the thymus of dexamethasone treated rats using [123I]annexin V and in situ oligonucleotide ligation.

Authors:  Katerina Zavitsanou; Vu Nguyen; Ivan Greguric; Janette Chapman; Patrice Ballantyne; Andrew Katsifis
Journal:  J Mol Histol       Date:  2007-06-29       Impact factor: 2.611

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.